Novo Nordisk stock surges on hopes Wegovy pill approval will deliver 'redemption' for investors [MSNBC.com]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: MSNBC.com
In this articleNovo Nordisksecure approvalThe U.S. Food and Drug Administration's approval of Novo Nordisk's GLP-1 pill gives the Danish pharmaceutical giant a head start over U.S. rivalEli Lilly"As the first oral GLP-1 treatment for people living with overweight or obesity, the Wegovy pill provides patients with a new, convenient treatment option that can help patients start or continue their weight loss journey," said Novo CEO Mike Doustdar in astatementShares closed 9.2% higher Tuesday.Stock Chart IconStock chart iconEli Lilly shares have outperformed Novo Nordisk in 2025.Novo plans to launch oral Wegovy, or "Wegovy-in-a-pill," in the U.S. – by far its largest market– in early January 2026. The company has also submitted the pill for approval to the European Medicines Agency (EMA) and other regulatory authorities.Wegovy's starting dose of 1.5 milligrams will be available in pharmacies and via telehealth providers with savings offers for $149 per month, Novo said.Cash-paying patien
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- European markets close at fresh high in final full session before Christmas [MSNBC.com]MSNBC.com
- Eli Lilly investors shouldn't sweat rival Novo Nordisk having the first obesity pill on sale [CNBC]CNBC
- US stocks approach records after mixed reports on economic growth, consumer confidence [Yahoo! Finance Canada]Yahoo! Finance Canada
- Stock market today: S&P 500, Nasdaq, Dow turn higher after surprise GDP growth trims rate-cut bets [Yahoo! Finance Canada]Yahoo! Finance Canada
- US stocks hold near their records after mixed reports on economic growth, consumer confidence [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
NVO
Earnings
- 11/6/25 - Beat
NVO
Sec Filings
- 12/23/25 - Form 6-K
- 11/25/25 - Form 6-K
- 11/24/25 - Form 6-K
- NVO's page on the SEC website